New treatment options for iron deficiency in women of different ages
DOI: 10.32364/2618-8430-2022-5-3-201-208
Yu.E. Dobrokhotova, E.A. Markova
Pirogov Russian National Research Medical University, Moscow, Russian Federation
Nowadays, iron-deficiency anemia (IDA) in pregnant and perimenopausal women has become an important social and healthcare problem. Despite the implementation of various projects and the availability of multiple clinical guidelines on early anemia diagnosis and prevention, no significant reduction in the global prevalence of IDA is observed. The article discusses the clinical efficacy of a new combination drug, containing ferrous sulfate and folic acid which is used for the treatment of iron deficiency during pregnancy, and the assessment of ferrous sulfate efficacy in perimenopausal women. The article presents a review of literature sources published in the last five years which describe the trials of sustained-release bivalent iron formulations with and without folic acid. The drugs were administered to women with gynecologic diseases that caused a chronic iron loss during menopause and to patients with iron deficiency during pregnancy. The authors discuss the most i mportant findings of the clinical trials assessing sustained-release bivalent iron formulation and its combination with folic acid which were used for treating pregnant women and gynecological patients of different ages. The literature data demonstrate that the combination drug, containing ferrous sulfate and folic acid is characterized by high clinical efficacy in the studied female populations with IDA.
Keywords: sideropenia, iron deficiency, iron-deficiency anemia, pregnancy, bivalent iron, folic acid, menopause, perimenopause, gynecological diseases.
For citation: Dobrokhotova Yu.E., Markova E.A. New treatment options for iron deficiency in women of different ages. Russian Journal of Woman and Child Health. 2022;5(3):201–208 (in Russ.). DOI: 10.32364/2618-8430-2022-5-3-201-208.
About the authors:
Yuliya E. Dobrokhotova — Dr. Sc. (Med.), Professor, Head of the Department of Obstetrics and Gynecology, Pirogov Russian National Research Medical University; 1, Ostrovityanov str., Moscow, 117997, Russian Federation; ORCID iD 0000-0002-7830-2290.
Eleonora A. Markova — C. Sc. (Med.), assistant of the Department of Obstetrics and Gynecology, Pirogov Russian National Research Medical University; 1, Ostrovityanov str., Moscow, 117997, Russian Federation; ORCID iD 0000-0002-9491-9303.
Contact information: Eleonora A. Markova, e-mail: markova.eleonora@mail.ru.
Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.
There is no conflict of interests.
Received 05.07.2022.
Revised 28.07.2022.
Accepted 22.08.2022.
2. Worldwide prevalence of anaemia 1993–2005. WHO Global Database On Anaemia. (Electronic resource.) URL: http://whqlibdoc.who.int/publications/2008/9789241596657_eng.pdf. (access date: 01.07.2022).
3. The World Health Organization (WHO). Vitamin and Mineral Nutrition Information System (VMNIS). (Electronic resource.) URL: https://www.who.int/teams/nutrition-and-food-safety/databases/vitamin-and-mineral-nutrition-information-system/data (access date: 01.07.2022).
4. Clinical guidelines "Iron deficiency anemia". 2021–2022–2023 (09.09.2021). (Electronic resource.) URL: http://gbpokachi.ru/upload/medialibrary/81b/hmct9ew0cod31zwgy2y2skydhvgcn4gk.pdf (access date: 01.07.2022) (in Russ.).
5. Camaschella C. Iron deficiency. Blood. 2019;133(1):30–39. DOI: 10.1182/blood-2018-05-815944.
6. Cappellini M.D., Musallam K.M., Taher A.T. Iron deficiency anaemia revisited. J Intern Med. 2020;287(2):153–170. DOI: 10.1111/joim.13004.
7. Lukina E.A., Dezhenkova A.V. Iron metabolism in normal and pathological conditions. Clinical oncohematology. 2015;8(4):355–361 (in Russ.). DOI: 10.21320/2500-2139-2015-8-4-355-361.
8. UNICEF, United Nations. University, United Nations Children’s Fund. Iron Deficiency Anaemia: Assessment, Prevention, and Control: a Guide for Programme Managers. World Health Organization; 2001.
9. Dobrokhotova Yu.E., Markova E.A. Correction of iron deficiency anemia in patients with obstetric and gynecological pathology (pharmacoeconomic comparative analysis). RMJ. 2018;2(1):29–33 (in Russ.).
10. Mirza F.G., Abdul-Kadir R., Breymann C. et al. Impact and management of iron deficiency and iron deficiency anemia in women’s health. Expert Rev Hematol. 2018;11(9):727–736. DOI: 10.1080/17474086.2018.1502081.
11. Milman N., Taylor C.L., Merkel J., Brannon P.M. Iron status in pregnant women and women of reproductive age in Europe. Am J Clin Nutr. 2017;106(Suppl 6):1655S–1662S. DOI: 10.3945/ajcn.117.156000.
12. Korotkova N.A., Prilepskaya V.N. Anaemia in pregnant women. Principles of therapy today. Meditsinskiy sovet — Medical Council. 2015;(XX):58–63 (in Russ.). DOI: 10.21518/2079-701X-2015-XX-58-63.
13. Firquet A., Kirschner W., Bitzer J. Forty to fifty-five-year-old women and iron deficiency: clinical considerations and quality of life. Gynecol Endocrinol. 2017;33(7):503–509.
14. Mansour D., Hofmann A., Gemzell-Danielsson K. A Review of Clinical Guidelines on the Management of Iron Deficiency and Iron-Deficiency Anemia in Women with Heavy Menstrual Bleeding. Adv Ther. 2021;38(1):201–225. DOI: 10.1007/s12325-020-01564-y.
15. Johnson S., Lang A., Sturm M., O’Brien S.H. Iron Deficiency without Anemia: A Common Yet Under-Recognized Diagnosis in Young Women with Heavy Menstrual Bleeding. J Pediatr Adolesc Gynecol. 2016;29(6):628–631. DOI: 10.1016/j.jpag.2016.05.009.
16. Instructions for the medical use of the drug Gyno-Tardiferon® (Electronic resource.) URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=e528be41–33a0–4036-a3c3–61f4bc249b46 (access date: 01.07.2022) (in Russ.).
17. Reddaiah V.P., Raj P.P., Ramachandran K. et al. Supplementary iron dose in pregnancy anemia prophylaxis. Indian J Pediatr. 1989;56(1):109–114. DOI: 10.1007/BF02749720.
18. Achebe M.M., Gafter-Gvili A. How I treat anemia in pregnancy: iron, cobalamin, and folate. Blood. 2017;129(8):940–949. DOI: 10.1182/blood-2016-08-672246.
19. King S.E., Yeh P.T., Rhee D.K. et al. Self-management of iron and folic acid supplementation during pre-pregnancy, pregnancy and postnatal periods: a systematic review. BMJ Glob Health. 2021;6(5):e005531. DOI: 10.1136/bmjgh-2021-005531.
20. Peña-Rosas J.P., De-Regil L.M., Garcia-Casal M.N., Dowswell T. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015;22;2015(7):CD004736. DOI: 10.1002/14651858.CD004736.pub5.
21. Polish Gynecological Society Expert Group. Stanowisko Zespołu Ekspertów Polskiego Towarzystwa Ginekologicznego dotyczace zastosowania preparatów zelaza (Tardyferon, Tardyferon-Fol) w połoznictwie i ginekologii [Statement of the Polish Gynecological Society Expert Group on the use of iron preparations (Tardyferon, Tardyferon-Fol) in obstetrics and gynaecology]. Ginekol Pol. 2013;84(1):72–74 (in Polish).
22. Sokolova M.Yu., Nikonov A.P. Iron deficiency anemia in pregnant women and its treatment with Gino-Tardiferon. Terapevticheskii arkhiv. 2003;78(7):87–89 (in Russ.).
23. Pavord S., Myers B., Robinson S. et al. British Committee for Standards in Haematology. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2012;156(5):588–600. DOI: 10.1111/j.1365-2141.2011.09012.x.
24. Demuth I.R., Martin A., Weissenborn A. Iron supplementation during pregnancy — a cross-sectional study undertaken in four German states. BMC Pregnancy Childbirth. 2018;18(1):491. DOI: 10.1186/s12884-018-2130-5.
25. Tyutyunnik V.L., Balushkina A.A., Dokueva R.S.-E. Prevention and treatment of iron deficiency anemia during pregnancy. Russian Journal of Woman and Child Health. 2013;21(1):22–25 (in Russ.).
26. Tyutyunnik V.L., Kan N.E., Mikhailova O.I. Correction of iron deficiency anemia in pregnant women. Obstetrics and gynecology. 2018;8:105–110 (in Russ.).
27. Goonewardene M., Shehata M., Hamad A. Anaemia in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2012;26(1):3–24. DOI: 10.1016/j.bpobgyn.2011.10.010.
28. The main indicators of maternal and child health, the activities of the child protection and obstetric services in the Russian Federation: Statistical compendium. M.; 2018 (in Russ.).
29. Nielsen P., Kongi R., Fischer R. Efficacy of a prolonged release iron preparation in iron deficiency anaemia. In: Proceedings of the 16th Wonca European Conference. 2010.
30. Zaim M., Piselli L., Fioravanti P., Kanony-Truc C. Efficacy and tolerability of a prolonged release ferrous sulphate formulation in iron deficiency anaemia: a non-inferiority controlled trial. Eur J Nutr. 2012;51(2):221–229. DOI: 10.1007/s00394-011-0210-7.
31. Sanghvi T.G., Harvey P.W.J., Wainwright E. Maternal iron-folic acid supplementation programs: evidence of impact and implementation. Food Nutr Bull. 2010;31:S100–107. DOI: 10.1177/15648265100312S202.
32. Peña-Rosas J.P., De-Regil L.M., Dowswell T., Viteri F.E. Intermittent oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2012;7(7):CD009997. DOI: 10.1002/14651858.CD009997.
33. Heavy menstrual bleeding: assessment and management. (Electronic resource.) URL: https://www.nice.org.uk/guidance/ng88 (access date: 01.07.2022).
34. Leary A., Barthe L., Clavel T. et al. Iron Pharmacokinetics in Women with Iron Deficiency Anaemia Following A Single Oral Dose of a Novel Formulation of Tardyferon (Prolonged Release Ferrous Sulphate). Drug Res (Stuttg). 2017;67(11):647–652. DOI: 10.1055/s-0043-113636.
35. Instructions for the medical use of the drug Tardiferon® (Electronic resource.) URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=49b438bb-9df9–4a79–8b07–89a5a4208c02 (access date: 01.07.2022) (in Russ.).
36. Coad J., Pedley K. Iron deficiency and iron deficiency anemia in women. Scand J Clin Lab Invest Suppl. 2014;244:82–89.
37. Stoianova V. Tardyferon in obstetric and gynaecological practice. Akush Ginecol (Sofiia). 2006;45(Suppl 3):76–77.
38. Dobrokhotova Yu.E., Bakhareva I.V. Iron deficiency anemia: prevention and treatment during pregnancy. Lechebnoye delo. 2016;3:4–14 (in Russ.).
39. Federal clinical guidelines. Diagnosis, prevention and treatment of iron deficiency conditions in pregnant women and puerperas. Russian Society of Obstetricians and Gynecologists FGBU "Scientific Center for Obstetrics, Gynecology and Perinatology named after A.I. IN AND. Kulakov" of the Ministry of Health of Russia. 2013. (Electronic resource.) URL: https://www.kamgov.ru/files/58195c5a740af1.38233436.pdf (access date: 01.07.2022) (in Russ.).
This work is licensed under a Creative Commons «Attribution» 4.0 License.
